EGFR and pulmonary fibrosis: In addition, EGFR-TKI can induce chronic inflammation in alveolar and bronchial epithelia, promote the migration and proliferation of fibroblasts, and stimulate the production of extracellular matrix, ultimately resulting in pulmonary fibrosis.